Shanghai Changzheng Hospital clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 128 studies whose lead sponsor is Shanghai Changzheng Hospital. 60 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 22, 2026.
Keep track of what changes. Save the Shanghai Changzheng Hospital studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesStatus
Where
- China
- 109
Focus areas
Conditions Shanghai Changzheng Hospital leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 128. Browse all 128 →
- HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric CancerRecruitingNCT07621484Phase 2
- Fecal Microbiota Transplantation for Obese Women With Polyendocrine Metabolic Ovarian SyndromeRecruitingNCT07746635Not applicable
- Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer (SINO-TOP)RecruitingNCT06238713Not applicable
- Screening, Classification, and Outcome Prediction Ensemble Using Orbital MRI for Thyroid Eye Disease: The TED SCOPE National Multicenter Registry StudyRecruitingNCT07716397
- MTS109 in Patients With Refractory Autoimmune DiseasesRecruitingNCT07526350Early Phase 1
- KCD (Carfilzomib/Cyclophosphamide/Dexamethasone) Regimen for the Treatment of Newly Diagnosed POEMS SyndromeRecruitingNCT07652879Phase 2
- Postoperative Neurological Recovery and Risk Factor Analysis in Patients With Paralysis Due to Spinal MetastasesNot yet recruitingNCT07527728
- HiSCs in the Treatment of Rheumatoid ArthritisRecruitingNCT06947746Not applicable
- A Study on the Correlation Between Tear Iron Levels and the Severity of Dry Eye Disease.RecruitingNCT07363824
- Anlotinib Combined With Sintilimab as First-line Treatment for Advanced Non-liver Metastatic Colorectal CancerRecruitingNCT07398326Phase 2
- Eye Tracking Study on Eye Movement Function and Visual Attention Patterns in Patients With Thyroid-Associated OphthalmopathyRecruitingNCT07381413
- Safety and Efficacy Evaluation of LC-K76 in Patients With Metastatic Hormone-Sensitive Prostate CancerNot yet recruitingNCT07389174Early Phase 1
- Safety and Preliminary Efficacy Evaluation of LC-K76 Plus Anti-PD-1 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)Not yet recruitingNCT07389187Early Phase 1
- Efficacy and Safety of Rifaximin-α in Treating MASLDRecruitingNCT07381257Early Phase 1
- A Study on the Changes of Glucose Metabolism and Exocrine Function in Patients With Chronic PancreatitisRecruitingNCT07314489Early Phase 1
- Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate CancerNot yet recruitingNCT07238959
- Efficacy and Safety of Rifaximin in Treating MAFLDRecruitingNCT07185932Early Phase 1
- Cardiovascular-Kidney-Metabolic Syndrome in Shanghai ZicitizensRecruitingNCT07043166
- Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment.RecruitingNCT07152366Phase 4
- The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment.RecruitingNCT07152340Phase 4
- Evaluation of the Efficacy and Safety Observation of IBI311 Treatment in Patients With Inactive TAORecruitingNCT07152392Phase 4
- Observational Study of Sacral Nerve Function After Sacral Tumor ResectionNot yet recruitingNCT07105644
- Inhaled Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Post-Infectious Cough: A Single-Center Randomized Controlled Clinical TrialRecruitingNCT07103980Phase 1/2
- A Dose-Expansion Trial of Intravenous HNF4α srRNA for Unresectable or Metastatic Colorectal CancerRecruitingNCT07050394Early Phase 1
- Pancreatic Cancer and Diabetes MellitusRecruitingNCT06585072
- Evaluation of the Efficacy and Safety of Absorbable vs Traditional Bone Wax for Facet Fusion After Lumbar Fusion SurgeryNot yet recruitingNCT07040293Not applicable
- Establishment of Multiparametric Prediction Models for Moderate to SevereThyroid Associated OphthalmopathyRecruitingNCT06590220
- MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.Not yet recruitingNCT07000292Phase 1/2
- A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α SrRNA in Treating Metastatic CRC PatientsRecruitingNCT06621173Early Phase 1
- A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC PatientsRecruitingNCT06418659Early Phase 1
- A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α srRNA in Treating Advanced ICC PatientsRecruitingNCT06583993Early Phase 1
- 5-MTHF Supplementation for Treatment of Type 1 Diabetes PatientsNot yet recruitingNCT06930144Not applicable
- The Aim of This Study is to Assess the Efficacy and Safety of Chidamide, Regorafenib in Combination With Iparomlimab and Tuvonralimab for the Treatment of Advanced Colorectal Cancer in Third-line Therapy and Subsequent Lines.RecruitingNCT06930118Phase 2
- Efficacy and Safety of LC-Z300-01 on Proteinuria in Diabetic PatientsNot yet recruitingNCT06686758Not applicable
- CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Locally Recurrent Colorectal CancerRecruitingNCT06881537Phase 2
- Efficacy and Safety of LC-Z300-01 in Chinese With Type 2 DiabetesNot yet recruitingNCT06847178Phase 2/3
- The Instant Efficacy and Safety of Alverine in Decreasing Portal Hypertension: an Exploratory Pilot StudyEnrolling by invitationNCT05508633Phase 2
- The Characteristics of Blood Glucose Profile and the Changes of Hormones in PPDM-C PopulationNot yet recruitingNCT06826729
- UCMSCs Combined With Allogeneic Islet Transplantation for the Treatment of DiabetesRecruitingNCT06751199Not applicable
- UCMSCs Combined With Standard Therapy for the Treatment of Newly Diagnosed Type 1 DiabetesRecruitingNCT06407297Not applicable
- a Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell LeukemiaRecruitingNCT06718270Early Phase 1
- Carvedilol and Alverine in Portal HypertensionNot yet recruitingNCT06696248Phase 2/3
- Irinotecan Hydrochloride Liposome Injection (Ⅱ) Combined with Fluorouracil, Folinic Acid, Vermofenib and Cetuximab in First-line Treatment of BRAFV600E Mutated Advanced Colorectal CancerRecruitingNCT06603376Phase 2
- Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG 2 (APICAL-GC)RecruitingNCT04278222Phase 2
- The Efficacy and Safety of Alverine in the Treatment of Portal Hypertension in Patients With Liver CirrhosisNot yet recruitingNCT06470386Phase 2/3
- Study of CT071 Injection in High Risk Newly Diagnosed Multiple MyelomaRecruitingNCT06407947Early Phase 1
- Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune DiseaseRecruitingNCT06373081Not applicable
- Utility of the Clamping Bean Test (CBT) for Covert Hepatic Encephalopathy ScreeningEnrolling by invitationNCT06367127
- Study of FasT CAR-T GC012F Injection NDMM PatientsRecruitingNCT05840107Early Phase 1
- Oral Prednisone in Treating LCH of Bone in Childhood and AdolescenceRecruitingNCT06078969Phase 2